Agenus

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Agenus and other ETFs, options, and stocks.

About AGEN

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777.

CEO

Garo H. Armen

CEOGaro H. Armen

Employees

389

Employees389

Headquarters

Lexington, Massachusetts

HeadquartersLexington, Massachusetts

Founded

1994

Founded1994

Employees

389

Employees389

AGEN Key Statistics

Market cap

155.21M

Market cap155.21M

Price-Earnings ratio

-0.53

Price-Earnings ratio-0.53

Dividend yield

—

Dividend yield—

Average volume

1.31M

Average volume1.31M

High today

$7.74

High today$7.74

Low today

$6.32

Low today$6.32

Open price

$6.84

Open price$6.84

Volume

1.27M

Volume1.27M

52 Week high

$42.60

52 Week high$42.60

52 Week low

$4.78

52 Week low$4.78

AGEN News

Benzinga 2d

Top 2 Health Care Stocks Which Could Rescue Your Portfolio This Month

Loading... Loading... The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indi...

Yahoo Finance 3d

Agenus Soars 6.8%: Is Further Upside Left in the Stock? - Yahoo Finance

Agenus (AGEN) shares rallied 6.8% in the last trading session to close at $5.31. This move can be attributable to notable volume with a higher number of shares...